Related references
Note: Only part of the references are listed.Pharmacotherapeutic management of T-cell acute lymphoblastic leukemia in adults: an update of the literature
Alexander Grunenberg et al.
EXPERT OPINION ON PHARMACOTHERAPY (2022)
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL
Sujan Piya et al.
LEUKEMIA (2022)
Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells
Elena Madrazo et al.
ONCOGENE (2022)
Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL
Kristina Mueller et al.
BLOOD (2022)
The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies
Mahdieh Mehrpouri
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Acute lymphoblastic leukemia-derived extracellular vesicles affect quiescence of hematopoietic stem and progenitor cells
Aleksandra Georgievski et al.
CELL DEATH & DISEASE (2022)
Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies
Valentina Cordo et al.
NATURE COMMUNICATIONS (2022)
Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies
Kamila Polgarova et al.
FRONTIERS IN ONCOLOGY (2022)
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia
Anna Montanaro et al.
CELL DEATH & DISEASE (2022)
Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
Robert J. Vanner et al.
BLOOD CANCER DISCOVERY (2022)
Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL
Praveen Anand et al.
BLOOD (2021)
More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment
Pilar Lopez-Nieva et al.
ONCOLOGIST (2021)
Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic Leukemia
Karen L. Bride et al.
HAEMATOLOGICA (2021)
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia
Charles Herbaux et al.
BLOOD (2021)
DNA Methylation in T-Cell Acute Lymphoblastic Leukemia: In Search for Clinical and Biological Meaning
Natalia Mackowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Venetoclax and navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Vinod A. Pullarkat et al.
CANCER DISCOVERY (2021)
Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma
Ana Silva et al.
BLOOD (2021)
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance
Jordy C. G. van der Zwet et al.
LEUKEMIA (2021)
The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL
Alessandra Di Grande et al.
BLOOD ADVANCES (2021)
Evaluation of Preclinical Activity of Isatuximab in Patients with Acute Lymphoblastic Leukemia
Anlai Wang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia
Quentin Van Thillo et al.
NATURE COMMUNICATIONS (2021)
PHF6 Mutations in Hematologic Malignancies
Jason H. Kurzer et al.
FRONTIERS IN ONCOLOGY (2021)
Physiologic IGFBP7 levels prolong IGF1R activation in acute lymphoblastic leukemia
Leonardo Luis Artico et al.
BLOOD ADVANCES (2021)
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia
Yoshihiro Gocho et al.
NATURE CANCER (2021)
Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia
Huizhong Xiong et al.
THERANOSTICS (2021)
Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphoma
Gautam Borthakur et al.
CANCER (2021)
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia
Yishai Ofran et al.
LEUKEMIA (2020)
New anti-IL-7Rα monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models
Julie A. Hixon et al.
LEUKEMIA (2020)
Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation
Rathana Kim et al.
LEUKEMIA (2020)
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects
Bruno Fattizzo et al.
FRONTIERS IN ONCOLOGY (2020)
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy
Prashant Ramesh Tembhare et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Tumor-associated myeloid cells provide critical support for T-ALL
Aram Lyu et al.
BLOOD (2020)
The Impact of Small Extracellular Vesicles on Lymphoblast Trafficking across the Blood-Cerebrospinal Fluid Barrier In Vitro
Ulrike Erb et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Myeloid cells hold the master key for T-ALL spread
Diana Passaro
BLOOD (2020)
Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia
Fatima Bayon-Calderon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia: A case report and review of literature
Nosha Farhadfar et al.
Hematology/ Oncology and Stem Cell Therapy (2020)
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia
Fabian Lang et al.
BMC PHARMACOLOGY & TOXICOLOGY (2020)
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia
Carlo Cuesta-Mateos et al.
BIOMARKER RESEARCH (2020)
Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells
Cedric S. Tremblay et al.
NATURE COMMUNICATIONS (2020)
The challenge to further improvements in survival of patients with T-ALL: Current treatments and new insights from disease pathogenesis
Kristen M. O'Dwyer
SEMINARS IN HEMATOLOGY (2020)
Bone marrow niches in haematological malignancies
Simon Mendez-Ferrer et al.
NATURE REVIEWS CANCER (2020)
Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment depends on stearoyl-CoA desaturase
Angela Maria Savino et al.
NATURE CANCER (2020)
The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells
Zhaodong Li et al.
LEUKEMIA (2019)
A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia
Padma Akkapeddi et al.
LEUKEMIA (2019)
Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition
Roger A. Habets et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia
Fotini Vogiatzi et al.
BLOOD (2019)
Structural and functional consequences of the STAT5BN642H driver mutation
Elvin D. de Araujo et al.
NATURE COMMUNICATIONS (2019)
IL-7R is essential for leukemia -initiating cell activity of T-cell acute lymphoblastic leukemia
Sara Gonzalez-Garcia et al.
BLOOD (2019)
CXCR4 Inhibition with BL-8040 in Combination with Nelarabine in Patients with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia / Lymphoblastic Lymphoma
Geoffrey L. Uy et al.
BLOOD (2019)
T Cell Acute Lymphoblastic Leukemia as a Consequence of Thymus Autonomy
Luna Ballesteros-Arias et al.
JOURNAL OF IMMUNOLOGY (2019)
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan et al.
NATURE MEDICINE (2019)
Phf6 Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL
Agnieszka A. Wendorff et al.
CANCER DISCOVERY (2019)
Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia
Delphine Verbeke et al.
HEMASPHERE (2019)
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia
Karen L. Bride et al.
BLOOD (2018)
MBD2 Ablation Impairs Lymphopoiesis and Impedes Progression and Maintenance of T-ALL
Mi Zhou et al.
CANCER RESEARCH (2018)
Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies
Amnon Peled et al.
CYTOKINE (2018)
Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies
Andrew E. Place et al.
FUTURE ONCOLOGY (2018)
The bone marrow microenvironment in health and disease at a glance
Rahul Kumar et al.
JOURNAL OF CELL SCIENCE (2018)
The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model
Marina Garcia-Peydro et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development
Charles E. de Bock et al.
CANCER DISCOVERY (2018)
FoxN1-dependent thymic epithelial cells promote T-cell leukemia development
Marinella N. Ghezzo et al.
CARCINOGENESIS (2018)
Epigenetic Restoration of Fetal-like IGF1 Signaling Inhibits Leukemia Stem Cell Activity
Vincenzo Giambra et al.
CELL STEM CELL (2018)
Safety and Efficacy of the BCL Inhibitors Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Andrew Hantel et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)
STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells
Daniel Ribeiro et al.
BLOOD ADVANCES (2018)
The CXCR4 Antagonist, BL8040, Is Highly Active Against Human T-ALL in Preclinical Models
Jun Xia et al.
BLOOD (2018)
The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system
Ameera Alsadeq et al.
HAEMATOLOGICA (2017)
Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway
Y. Shen et al.
LEUKEMIA (2017)
The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system
Ameera Alsadeq et al.
HAEMATOLOGICA (2017)
JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias
C. Delgado-Martin et al.
LEUKEMIA (2017)
Leukemia-initiating Cells in T-Cell Acute Lymphoblastic Leukemia
Shi Hao Tan et al.
FRONTIERS IN ONCOLOGY (2017)
Adult haematopoietic stem cell niches
Genevieve M. Crane et al.
NATURE REVIEWS IMMUNOLOGY (2017)
AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth
V. Lokesh Battula et al.
JCI INSIGHT (2017)
Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA
Itaru Kato et al.
BLOOD (2017)
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
Viktoras Frismantas et al.
BLOOD (2017)
CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia
N. Jena et al.
LEUKEMIA (2016)
Aberrant Notch Signaling in the Bone Marrow Microenvironment of Acute Lymphoid Leukemia Suppresses Osteoblast-Mediated Support of Hematopoietic Niche Function
Weihuan Wang et al.
CANCER RESEARCH (2016)
Microenvironmental cues for T-cell acute lymphoblastic leukemia development
Diana Passaro et al.
IMMUNOLOGICAL REVIEWS (2016)
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway
Annalisa Lonetti et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia
Tanja Rezzonico Jost et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling
C. S. Tremblay et al.
LEUKEMIA (2016)
MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia
K. Cante-Barrett et al.
LEUKEMIA (2016)
T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments
Edwin D. Hawkins et al.
NATURE (2016)
IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study
Yunlei Li et al.
PLOS MEDICINE (2016)
The genetics and mechanisms of T cell acute lymphoblastic leukaemia
Laura Belver et al.
NATURE REVIEWS CANCER (2016)
Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling
Vincenzo Giambra et al.
BLOOD (2015)
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia
Shannon L. Maude et al.
BLOOD (2015)
Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL
Isabelle Bartram et al.
BMC CANCER (2015)
Lymphotoxin-β receptor in microenvironmental cells promotes the development of T-cell acute lymphoblastic leukaemia with cortical/mature immunophenotype
Monica T. Fernandes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
T-ALL: Home Is where the CXCL12 Is
Charles E. de Bock et al.
CANCER CELL (2015)
CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia
Diana Passaro et al.
CANCER CELL (2015)
CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance
Lauren A. Pitt et al.
CANCER CELL (2015)
A hostel for the hostile: the bone marrow niche in hematologic neoplasms
Daniela S. Krause et al.
HAEMATOLOGICA (2015)
Organ-Specific Microenvironment Modifies Diverse Functional and Phenotypic Characteristics of Leukemia-Associated Macrophages in Mouse T Cell Acute Lymphoblastic Leukemia
Sha-Yan Chen et al.
JOURNAL OF IMMUNOLOGY (2015)
A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
Cristina Papayannidis et al.
BLOOD CANCER JOURNAL (2015)
A hostel for the hostile: the bone marrow niche in hematologic neoplasms
Daniela S. Krause et al.
HAEMATOLOGICA (2015)
Epigenetics in T-cell acute lymphoblastic leukemia
Sofie Peirs et al.
IMMUNOLOGICAL REVIEWS (2015)
c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells
Justine E. Roderick et al.
BLOOD (2014)
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model
Sandrine Degryse et al.
BLOOD (2014)
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
Sofie Peirs et al.
BLOOD (2014)
Clonal Evolution Enhances Leukemia-Propagating Cell Frequency in T Cell Acute Lymphoblastic Leukemia through Akt/mTORC1 Pathway Activation
Jessica S. Blackburn et al.
CANCER CELL (2014)
Targeting the MYC and PI3K Pathways Eliminates Leukemia-Initiating Cells in T-cell Acute Lymphoblastic Leukemia
Suzanne Schubbert et al.
CANCER RESEARCH (2014)
Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia
Thomas Trimarchi et al.
CELL (2014)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential
Louise M. Treanor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Notch1-induced T cell leukemia can be potentiated by microenvironmental cues in the spleen
Shihui Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts
V. Agnusdei et al.
LEUKEMIA (2014)
Cell competition is a tumour suppressor mechanism in the thymus
Vera C. Martins et al.
NATURE (2014)
SCL, LMO1 and Notch1 Reprogram Thymocytes into Self-Renewing Cells
Bastien Gerby et al.
PLOS GENETICS (2014)
The CXCR4/CXCL12 Axis Mediates Chemotaxis, Survival, and Chemoresistance in T-Cell Acute Lymphoblastic Leukemia
Angela Liou et al.
BLOOD (2014)
Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia
Paraskevi Diamanti et al.
BLOOD (2013)
Divergent effects of supraphysiologic Notch signals on leukemia stem cells and hematopoietic stem cells
Mark Y. Chiang et al.
BLOOD (2013)
The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
Bryan King et al.
CELL (2013)
Notch1 Receptor Regulates AKT Protein Activation Loop (Thr308) Dephosphorylation through Modulation of the PP2A Phosphatase in Phosphatase and Tensin Homolog (PTEN)-null T-cell Acute Lymphoblastic Leukemia Cells
Eric C. Hales et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Notch1 Gene Mutations Target KRAS G12D-expressing CD8+ Cells and Contribute to Their Leukemogenic Transformation
Guangyao Kong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response
C. Shepherd et al.
LEUKEMIA (2013)
Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia
S. Gachet et al.
LEUKEMIA (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders
Rafael Tabares-Seisdedos et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
Ashley Hamilton et al.
BLOOD (2012)
Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia
Catherine M. Sawai et al.
CANCER CELL (2012)
Thymocytes may persist and differentiate without any input from bone marrow progenitors
Laetitia Peaudecerf et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Thymus-autonomous T cell development in the absence of progenitor import
Vera C. Martins et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Preclinical Analysis of the γ-Secretase Inhibitor PF-03084014 in Combination with Glucocorticoids in T-cell Acute Lymphoblastic Leukemia
Jeremy B. Samon et al.
MOLECULAR CANCER THERAPEUTICS (2012)
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications
C. Grimaldi et al.
LEUKEMIA (2012)
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia
C. Simioni et al.
LEUKEMIA (2012)
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang et al.
NATURE (2012)
NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species
Vincenzo Giambra et al.
NATURE MEDICINE (2012)
The Novel CXCR4 Antagonist POL5551 Decreases Surface CXCR4 (s-CXCR4) Expression, Inhibits Chemotaxis, and Enhances Chemosensitivity in Acute Lymphoblastic Leukemia (ALL)
Edward Allan R. Sison et al.
BLOOD (2012)
Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL
Jessica Tatarek et al.
BLOOD (2011)
Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease
Ruth M. Risueno et al.
BLOOD (2011)
IL-7 Contributes to the Progression of Human T-cell Acute Lymphoblastic Leukemias
Ana Silva et al.
CANCER RESEARCH (2011)
High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling
Hind Medyouf et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
Chen Shochat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations
B. Gerby et al.
LEUKEMIA (2011)
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
Priscila P. Zenatti et al.
NATURE GENETICS (2011)
Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance
Priscilla P. L. Chiu et al.
BLOOD (2010)
High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia
Alexandra C. H. Smith et al.
BLOOD (2010)
Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes
Mathieu Tremblay et al.
GENES & DEVELOPMENT (2010)
Evaluation of Selective gamma-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Ping Wei et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Therapeutic antibody targeting of individual Notch receptors
Yan Wu et al.
NATURE (2010)
Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors
Miguel Aste-Amezaga et al.
PLOS ONE (2010)
Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases
Ila Joshi et al.
BLOOD (2009)
NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity
Florence Armstrong et al.
BLOOD (2009)
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
Alejandro Gutierrez et al.
BLOOD (2009)
Phase II Study of Alemtuzumab in Combination With Pentostatin in Patients With T-Cell Neoplasms
Farhad Ravandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia
W. Deenik et al.
LEUKEMIA (2009)
The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group
A. Larson Gedman et al.
LEUKEMIA (2009)
Heritable T-cell malignancy models established in a zebrafish phenotypic screen
J. K. Frazer et al.
LEUKEMIA (2009)
CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia
Silvia Buonamici et al.
NATURE (2009)
A Phase II Study of Campath-1H in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia: A Children's Oncology Group Report
Anne L. Angiolillo et al.
PEDIATRIC BLOOD & CANCER (2009)
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia
Mark Y. Chiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies
A. Quintas-Cardama et al.
LEUKEMIA (2008)
Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation
Wei Guo et al.
NATURE (2008)
Molecular pathogenesis of T-cell leukaemia and lymphoma
Iannis Aifantis et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Teresa Palomero et al.
NATURE MEDICINE (2007)
Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia
Hind Medyouf et al.
NATURE MEDICINE (2007)
Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia
Charlotte V. Cox et al.
BLOOD (2007)
Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia
C Grabher et al.
NATURE REVIEWS CANCER (2006)
Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL)
R Fukuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
γ-secretase-mediated proteolysis in cell-surface-receptor signalling
ME Fortini
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia
R Crazzolara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
